Dissecting the Genetic Variations Associated with Response to First-Line Chemotherapy in Patients with Small Cell Lung Cancer: A Retrospective Cohort Study

    December 2023 in “ Journal of Thoracic Disease ”
    Yalei Zhang, Hao Yan, Hui Pan, Hongbo Zheng, Jiaqi Zhou
    TLDR Increased EGFR gene variations may predict chemotherapy outcomes in small cell lung cancer patients.
    The study investigates the genetic variations associated with the response to first-line chemotherapy in patients with small cell lung cancer (SCLC). It identifies that increased <i>EGFR</i> gene copy number variations (CNVs) may serve as an independent indicator affecting both the survival time and partial response (PR) in SCLC patients undergoing standard first-line chemotherapy. This suggests that <i>EGFR</i> CNVs could potentially be used as a biomarker to predict treatment outcomes in these patients.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results